HCLS1 associated protein X-1 enhances tongue squamous cell carcinoma burden by driving K835 L-lactylation of DEAD-box helicase 24
L-lactylation converts tumor metabolic byproducts into global commanders that drive metabolic reprogramming, drug resistance, and immune evasion. However, the epigenetic mechanism underlying L-lactylation in tongue squamous cell carcinoma (TSCC) remains unidentified. This study employed modified proteomics and bioinformatics to identify mechanisms related to L-lactylation in the TSCC progression. HAX1 knockout and stable overexpression cell lines were established using CRISPR/Cas9 and lentivirus. Subsequently, the effects of L-lactylation mediated by the HAX1/DDX24 axis on TSCC burden were investigated in vivo and in vitro through rescue experiments. We found that HAX1 was consistently identified as a prognostic risk target across four TSCC-related datasets GSE143950, GSE149008, GSE156178, TCGA-OSCC, showing high expression in TSCC tissues and increasing with stage. HAX1 −/− effectively restricted the growth, metastasis, glycolysis and tumor burden of Cal27 and SCC4 cells, while its overexpression exhibited the opposite regulatory pattern. In post-translational modification analysis, HAX1 −/− downregulated the levels of acetylation, β-hydroxybutyrylation, L-lactyllysine, and succinylation, and upregulated crotonylation, particularly of L-lactyllysine. L-lactylation proteomics confirmed that DDX24 was a downstream target associated with HAX1-mediated L-lactylation, and its prognostic value and expression pattern were similar to those of HAX1. Moreover, HAX1 and lactate effectively upregulated DDX24 K835 L-lactylation in TSCC cells. Importantly, DDX24 knockdown restricts HAX1-mediated malignant phenotypes, whereas DDX24 overexpression had the opposite effect. In conclusion, HAX1 is an independent risk factor for TSCC progression and contributes to tumor burden by driving DDX24 K835 L-lactylation. This discovery holds promise for driving the development of new strategies targeting epigenetic and metabolic reprogramming in TSCC.
Authors
- Hui Guo (ORCID: https://orcid.org/0000-0002-6203-6792)
- Zhou Heng-min
- Peiqi Hao
- Jin-song Pan
- Yang Liu
- Xin-yu Zhang
- Xing Xu
Institutions
- Kunming University of Science and Technology (CN)
- Ruijin Hospital (CN)
- First People's Hospital of Yunnan Province (CN)
Publication Details
- Journal
- Cell Communication and Signaling
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1186/s12964-026-03371-4
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China